Related Experiment Video
Updated: Feb 5, 2026

Sample Preparation to Bioinformatics Analysis of DNA Methylation: Association Strategy for Obesity and Related Trait Studies
Published on: May 6, 2022
Integrated bioinformatic analysis of microarray data reveals shared gene signature between MDS and AML
Zhen Zhang1, Lin Zhao1, Xijin Wei2
1Laboratory for Molecular Immunology, Institute of Basic Medicine, Shandong Academy of Medical Sciences, Jinan, Shandong 250062, P.R. China.
This study identified shared molecular pathways and gene signatures in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). Findings clarify the link between these myeloid disorders, aiding biomarker discovery.
Area of Science:
- Hematology
- Molecular Biology
- Genomics
Background:
- Myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) are significant global health burdens.
- Common molecular underpinnings of MDS and AML development are not fully understood.
- Identifying shared genetic factors is crucial for understanding disease progression.
Purpose of the Study:
- To identify shared gene signatures and biological processes between MDS and AML using meta-analysis.
- To elucidate the molecular mechanisms linking MDS and AML.
- To discover potential diagnostic, therapeutic, and prognostic biomarkers.
Main Methods:
- Meta-analysis of 18 microarray datasets using NetworkAnalyst.
- Identification of differentially expressed genes (DEGs) in MDS and AML.
- Functional enrichment analysis and network-based meta-analysis.
Main Results:
- 191 upregulated genes (e.g., PTH2R, TEC, GPX1) and 139 downregulated genes (e.g., MME, RAG1, CD79B) identified.
- Upregulated pathways include oncogenic signaling and fibroblast growth factor receptor (FGFR) signaling.
- Downregulated pathways include interleukin-6/interferon and B cell receptor signaling.
- HSP90AA1 and CUL1 identified as key hub genes.
Conclusions:
- This study clarifies the molecular relationship between MDS and AML.
- Identified gene signatures and pathways provide insights into disease development and transition.
- Findings support the development of novel biomarkers for MDS and AML.
Related Concept Videos
Analysis of Population Pharmacokinetic Data
Overview of Microsoft Excel as a Data Analysis Tool
DNA Microarrays
Performing a Simple Data Analysis using MS-Excel Function
SUM: This function calculates the total sum of a range of values. It's the foundation for aggregating data, essential for determining overall trends and totals in datasets.
AVERAGE: It computes the mean value of a given set of numbers, providing a quick insight into the central...
Statistical Software for Data Analysis and Clinical Trials
Gene Therapy

